Gary M Lekander, MD
Pulmonary Disease · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · Aretaeus Telemedicine Inc
Looking this up.
Hospitals listed: Adventist Health Howard Memorial · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lekander’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G85799 · Current
Licensed to practise in California · since 2000 · expires 2027-11-30 · University of Texas Medical Branch at Galveston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Howard MemorialWillits, CACritical Access Hospital · Voluntary non-profit - Private · No emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Howard Memorial
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 11.3 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 398 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 47 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 18.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 16.7) · 231 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 232 cases | No different | Jan 2024 – Dec 2024 |
What patients said (179 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$206,093
Medicare paid this office $206,093 for 796 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 328 | $49,179 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 60 | $24,560 | $40 |
| Test to examine how well the lungs exchange gases | 414 | $22,954 | $52 |
| Long return visit (40+ min) | 132 | $20,799 | $144 |
| Test to determine lung volumes using gas dilution or washout | 415 | $17,449 | $39 |
See all 15 services
| Return visit (30+ min) | 328 | $49,179 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 60 | $24,560 | $40 |
| Test to examine how well the lungs exchange gases | 414 | $22,954 | $52 |
| Long return visit (40+ min) | 132 | $20,799 | $144 |
| Test to determine lung volumes using gas dilution or washout | 415 | $17,449 | $39 |
| New patient visit (45+ min) | 118 | $15,955 | $135 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 434 | $15,286 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $7,937 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $6,923 | $107 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 334 | $6,820 | $14 |
| Critical care, first 30-74 minutes | 26 | $5,801 | $166 |
| Short return visit (20+ min) | 52 | $4,390 | $72 |
| New patient visit (60+ min) | 17 | $3,048 | $179 |
| Test for exercise-induced lung stress | 93 | $1,869 | $19 |
| Test to measure oxygen level in blood using ear or finger device multiple times | 18 | $44 | $2 |
Who their Medicare patients are
796 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 12% · Women 59% · Also on Medicaid 23% · Health risk score 1.69. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 73% · COPD 56% · Coronary heart disease 38% · Heart failure 29% · Atrial fibrillation 29% · Depression 29% · Diabetes 26% · Chronic kidney disease 23% · Cancer 16% · Stroke 10% · Dementia 6%.
The office billed $898,317, Medicare allowed $270,602 and paid $206,093; for 3,657 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 796 | 3,657 | 75 | 1.69 | $898,317 | $206,093 |
| 2023 | 480 | 1,720 | 74 | 1.91 | $557,777 | $150,949 |
| 2022 | 157 | 1,188 | 73 | 2.59 | $314,027 | $95,283 |
| 2021 | 206 | 414 | 75 | 1.71 | $105,278 | $40,266 |
| 2020 | 315 | 742 | 74 | 1.99 | $178,663 | $64,061 |
| 2019 | 335 | 953 | 74 | 1.92 | $214,523 | $85,735 |
| 2018 | 359 | 996 | 74 | 2.07 | $241,020 | $94,476 |
| 2017 | 213 | 421 | 73 | 2.16 | $133,232 | $50,296 |
| 2016 | 157 | 298 | 73 | 2.13 | $112,445 | $37,768 |
| 2015 | 174 | 326 | 74 | 1.92 | $110,501 | $41,526 |
| 2014 | 190 | 392 | 76 | 1.87 | $112,599 | $42,972 |
| 2013 | 254 | 612 | 73 | 1.65 | $164,061 | $60,723 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $31,832 | $65 |
| Return visit (30+ min) | 162 | $22,152 | $110 |
| Long return visit (40+ min) | 124 | $20,350 | $153 |
| Critical care, first 30-74 minutes | 47 | $14,311 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $12,802 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $9,950 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,259 | $108 |
| Test to examine how well the lungs exchange gases | 116 | $6,129 | $52 |
| New patient visit (45+ min) | 34 | $4,765 | $140 |
| New patient visit (60+ min) | 25 | $4,697 | $188 |
| Test to determine lung volumes using gas dilution or washout | 115 | $4,613 | $40 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 111 | $3,920 | $34 |
| Short return visit (20+ min) | 21 | $1,801 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $1,350 | $41 |
| Diagnostic exam of lung airway using an endoscope | 11 | $1,178 | $107 |
| Test to measure oxygen level in blood using ear or finger device multiple times | 23 | $77 | $3 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $41,302 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $17,841 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $10,605 | $85 |
| Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth | 24 | $9,728 | $162 |
| Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | 24 | $4,232 | $176 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $3,762 | $32 |
| Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 17 | $2,663 | $86 |
2021: 8 services
| Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth | 26 | $7,641 | $159 |
| Short return visit (20+ min) | 80 | $5,816 | $57 |
| Telephone medical discussion with physician, 21-30 minutes | 49 | $5,309 | $86 |
| Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 23 | $4,265 | $87 |
| Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | 21 | $3,551 | $169 |
| New patient visit (45+ min) | 31 | $3,109 | $100 |
| Return visit (30+ min) | 24 | $2,627 | $109 |
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 11 | $1,856 | $169 |
2020: 10 services
| Short return visit (20+ min) | 181 | $18,458 | $62 |
| Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth | 29 | $12,006 | $160 |
| Return visit (30+ min) | 100 | $8,506 | $70 |
| New patient visit (45+ min) | 53 | $6,490 | $122 |
| Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | 23 | $4,028 | $175 |
| New patient visit (60+ min) | 18 | $2,654 | $147 |
| New patient visit (30+ min) | 15 | $1,281 | $85 |
| Test to examine how well the lungs exchange gases | 21 | $805 | $38 |
| Test to determine lung volumes using gas dilution or washout | 21 | $656 | $31 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $536 | $38 |
2019: 13 services
| Return visit (30+ min) | 194 | $32,158 | $85 |
| New patient visit (60+ min) | 102 | $16,384 | $161 |
| Critical care, first 30-74 minutes | 17 | $6,193 | $182 |
| Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth | 13 | $4,918 | $159 |
| Long return visit (40+ min) | 30 | $3,699 | $109 |
| Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | 19 | $3,195 | $168 |
| Test to examine how well the lungs exchange gases | 71 | $3,185 | $44 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 55 | $2,929 | $52 |
| New patient visit (45+ min) | 22 | $2,893 | $132 |
| Short return visit (20+ min) | 36 | $2,675 | $64 |
| Test to determine lung volumes using gas dilution or washout | 70 | $2,564 | $36 |
| Test for exercise-induced lung stress | 39 | $1,196 | $29 |
| Test to measure rate of airflow | 15 | $421 | $28 |
2018: 14 services
| Return visit (30+ min) | 155 | $23,062 | $83 |
| Critical care, first 30-74 minutes | 56 | $17,879 | $174 |
| New patient visit (60+ min) | 109 | $16,721 | $153 |
| Long return visit (40+ min) | 67 | $7,912 | $113 |
| Test to examine how well the lungs exchange gases | 81 | $3,675 | $45 |
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 23 | $3,607 | $157 |
| Test to determine lung volumes using gas dilution or washout | 80 | $2,942 | $37 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 59 | $2,906 | $49 |
| Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth | 13 | $2,855 | $150 |
| Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | 17 | $2,645 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,592 | $79 |
| Test for exercise-induced lung stress | 31 | $874 | $28 |
| Short return visit (20+ min) | 11 | $719 | $60 |
| Test to measure rate of airflow | 20 | $673 | $34 |
2017: 6 services
| Critical care, first 30-74 minutes | 53 | $16,122 | $173 |
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 76 | $10,617 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $6,023 | $77 |
| Return visit (30+ min) | 38 | $5,175 | $86 |
| New patient visit (60+ min) | 31 | $4,918 | $159 |
| New patient visit (45+ min) | 11 | $1,437 | $131 |
2016: 3 services
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 81 | $13,654 | $152 |
| Critical care, first 30-74 minutes | 42 | $11,577 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $7,454 | $79 |
2015: 3 services
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 120 | $20,462 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $10,834 | $82 |
| Critical care, first 30-74 minutes | 18 | $8,190 | $178 |
2014: 6 services
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 92 | $16,019 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $9,810 | $84 |
| Critical care, first 30-74 minutes | 21 | $7,701 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,234 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,793 | $163 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,433 | $84 |
2013: 8 services
| Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | 74 | $12,079 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $11,000 | $80 |
| Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 54 | $10,730 | $82 |
| Critical care, first 30-74 minutes | 26 | $8,859 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,704 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $5,288 | $56 |
| Hospital discharge day management, more than 30 minutes | 40 | $3,294 | $80 |
| Hospital observation care on day of discharge | 12 | $684 | $57 |
Medicaid work
$49,362 in 2024
Medicaid paid $49,362 for 1,097 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 629 | $25,550 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 135 | $6,287 |
| Diffusing capacity | 95 | $5,548 |
| EVALUATION OF WHEEZING | 100 | $5,262 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 95 | $4,443 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $1,428 |
| Return visit (30+ min) | 27 | $846 |
| 2024 | 1,097 | 7 | 22 | $49,362 |
| 2023 | 257 | 4 | 15 | $14,995 |
| 2019 | 28 | 1 | 15 | $1,655 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 204 | $13,767 |
| Diffusing capacity | 18 | $473 |
| EVALUATION OF WHEEZING | 19 | $402 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 16 | $353 |
2019
| Return visit (30+ min) | 28 | $1,655 |
Drugs they prescribed that Part D paid
$637,836
Pharmacies billed $637,836 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,333) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
246 generic and 1,087 brand-name prescriptions · $637,836 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 374 | $282,913 | $756 |
| Anoro Ellipta | 253 | $165,518 | $654 |
| Breo Ellipta | 68 | $44,828 | $659 |
| Spiriva Respimat | 47 | $37,265 | $793 |
| Incruse Ellipta | 52 | $25,450 | $489 |
See all 19 drugs
| Trelegy Ellipta | 374 | $282,913 | $756 |
| Anoro Ellipta | 253 | $165,518 | $654 |
| Breo Ellipta | 68 | $44,828 | $659 |
| Spiriva Respimat | 47 | $37,265 | $793 |
| Incruse Ellipta | 52 | $25,450 | $489 |
| Stiolto Respimat | 24 | $14,002 | $583 |
| Fluticasone-Vilanterol | 23 | $8,972 | $390 |
| Pirfenidone | 12 | $7,226 | $602 |
| Symbicort | 27 | $6,970 | $258 |
| Fluticasone-Salmeterol | 37 | $5,909 | $160 |
| Albuterol Sulfate Hfa | 173 | $4,343 | $25 |
| Breyna | 18 | $4,042 | $225 |
| Budesonide-Formoterol | 12 | $2,680 | $223 |
| Wixela Inhub | 17 | $2,454 | $144 |
| Ventolin Hfa | 42 | $2,310 | $55 |
| Ipratropium | 16 | $1,742 | $109 |
| Azelastine | 19 | $521 | $27 |
| Montelukast | 27 | $319 | $12 |
| Fluticasone Propionate | 20 | $182 | $9 |
Year by year
| 2024 | 1,333 | 300 | 0% (0) | 82% | $637,836 |
| 2023 | 607 | 188 | 0% (0) | 86% | $319,551 |
| 2022 | 379 | 87 | 0% (0) | 91% | $220,684 |
| 2021 | 1,140 | 180 | None | 91% | $563,328 |
| 2020 | 1,494 | 211 | 0% (0) | 91% | $684,214 |
| 2019 | 1,428 | 213 | 0% (0) | 89% | $570,449 |
| 2018 | 935 | 165 | 0% (0) | 88% | $339,715 |
| 2017 | 506 | 93 | 0% (0) | 85% | $129,801 |
| 2016 | 287 | 56 | 0% (0) | 67% | $55,331 |
| 2015 | 275 | 46 | 0% (0) | 61% | $44,736 |
| 2014 | 220 | 38 | None | 55% | $31,711 |
| 2013 | 107 | 35 | 0% (0) | 47% | $10,517 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Trelegy Ellipta | 115 | $92,643 | $806 |
| Anoro Ellipta | 118 | $85,710 | $726 |
| Breo Ellipta | 51 | $30,735 | $603 |
| Spiriva Respimat | 17 | $19,539 | $1,149 |
| Symbicort | 29 | $17,479 | $603 |
| Incruse Ellipta | 31 | $15,309 | $494 |
| Stiolto Respimat | 16 | $10,085 | $630 |
| Albuterol Sulfate Hfa | 83 | $3,064 | $37 |
| Ventolin Hfa | 37 | $2,530 | $68 |
| Montelukast | 11 | $213 | $19 |
2022: 8 drugs
| Trelegy Ellipta | 96 | $75,066 | $782 |
| Anoro Ellipta | 59 | $49,278 | $835 |
| Spiriva Respimat | 27 | $22,591 | $837 |
| Symbicort | 33 | $16,926 | $513 |
| Breo Ellipta | 20 | $15,477 | $774 |
| Incruse Ellipta | 25 | $11,763 | $471 |
| Arnuity Ellipta | 14 | $4,177 | $298 |
| Albuterol Sulfate Hfa | 36 | $1,981 | $55 |
2021: 16 drugs
| Trelegy Ellipta | 227 | $168,583 | $743 |
| Anoro Ellipta | 220 | $136,324 | $620 |
| Spiriva Respimat | 105 | $69,002 | $657 |
| Breo Ellipta | 130 | $62,719 | $482 |
| Symbicort | 32 | $19,671 | $615 |
| Incruse Ellipta | 30 | $14,782 | $493 |
| Arnuity Ellipta | 61 | $14,731 | $241 |
| Stiolto Respimat | 23 | $12,349 | $537 |
| Spiriva | 17 | $11,324 | $666 |
| Advair Diskus | 15 | $8,758 | $584 |
| Bevespi Aerosphere | 17 | $8,694 | $511 |
| Albuterol Sulfate Hfa | 89 | $5,618 | $63 |
| Ventolin Hfa | 39 | $3,057 | $78 |
| Azithromycin | 11 | $323 | $29 |
| Montelukast | 14 | $228 | $16 |
| Fluticasone Propionate | 14 | $205 | $15 |
2020: 20 drugs
| Trelegy Ellipta | 259 | $179,722 | $694 |
| Anoro Ellipta | 296 | $164,900 | $557 |
| Breo Ellipta | 186 | $84,766 | $456 |
| Spiriva Respimat | 127 | $70,422 | $555 |
| Symbicort | 53 | $24,401 | $460 |
| Incruse Ellipta | 44 | $23,146 | $526 |
| Stiolto Respimat | 37 | $20,546 | $555 |
| Advair Hfa | 19 | $13,578 | $715 |
| Spiriva | 19 | $10,923 | $575 |
| Arnuity Ellipta | 51 | $10,226 | $201 |
| Ventolin Hfa | 107 | $6,850 | $64 |
| Flovent Hfa | 13 | $5,018 | $386 |
| Albuterol Sulfate Hfa | 76 | $4,886 | $64 |
| Dulera | 13 | $4,502 | $346 |
| Wixela Inhub | 17 | $3,562 | $210 |
| Proair Hfa | 23 | $1,740 | $76 |
| Azithromycin | 30 | $1,008 | $34 |
| Theo-24 | 13 | $998 | $77 |
| Fluticasone Propionate | 21 | $346 | $16 |
| Prednisone | 12 | $97 | $8 |
2019: 20 drugs
| Anoro Ellipta | 312 | $156,646 | $502 |
| Trelegy Ellipta | 244 | $153,258 | $628 |
| Breo Ellipta | 143 | $56,347 | $394 |
| Spiriva Respimat | 57 | $36,341 | $638 |
| Spiriva | 53 | $25,152 | $475 |
| Incruse Ellipta | 36 | $18,994 | $528 |
| Symbicort | 47 | $16,902 | $360 |
| Stiolto Respimat | 34 | $15,705 | $462 |
| Advair Hfa | 14 | $9,444 | $675 |
| Pulmicort Flexhaler | 23 | $9,426 | $410 |
| Arnuity Ellipta | 43 | $9,349 | $217 |
| Ventolin Hfa | 127 | $7,834 | $62 |
| Advair Diskus | 12 | $4,988 | $416 |
| Dulera | 14 | $4,523 | $323 |
| Proair Hfa | 36 | $2,658 | $74 |
| Albuterol Sulfate Hfa | 25 | $1,652 | $66 |
| Azithromycin | 27 | $825 | $31 |
| Fluticasone Propionate | 16 | $344 | $22 |
| Montelukast | 11 | $259 | $24 |
| Prednisone | 46 | $185 | $4 |
2018: 18 drugs
| Anoro Ellipta | 204 | $92,360 | $453 |
| Trelegy Ellipta | 80 | $44,251 | $553 |
| Breo Ellipta | 108 | $38,528 | $357 |
| Spiriva | 72 | $28,777 | $400 |
| Incruse Ellipta | 63 | $27,829 | $442 |
| Advair Diskus | 26 | $12,250 | $471 |
| Symbicort | 37 | $11,636 | $314 |
| Stiolto Respimat | 26 | $11,413 | $439 |
| Spiriva Respimat | 12 | $7,664 | $639 |
| Arnuity Ellipta | 27 | $5,762 | $213 |
| Pulmicort Flexhaler | 13 | $5,342 | $411 |
| Ventolin Hfa | 90 | $5,005 | $56 |
| Proair Hfa | 40 | $2,664 | $67 |
| Fluticasone Propionate | 20 | $426 | $21 |
| Levofloxacin | 11 | $319 | $29 |
| Montelukast | 19 | $296 | $16 |
| Pantoprazole | 12 | $156 | $13 |
| Prednisone | 23 | $152 | $7 |
2017: 12 drugs
| Anoro Ellipta | 124 | $46,507 | $375 |
| Spiriva | 58 | $22,129 | $382 |
| Advair Diskus | 34 | $14,440 | $425 |
| Symbicort | 41 | $11,753 | $287 |
| Breo Ellipta | 27 | $10,087 | $374 |
| Flovent Hfa | 15 | $4,720 | $315 |
| Ventolin Hfa | 50 | $2,672 | $53 |
| Proair Hfa | 28 | $2,056 | $73 |
| Arnuity Ellipta | 11 | $1,757 | $160 |
| Pantoprazole | 15 | $117 | $8 |
| Azithromycin | 11 | $109 | $10 |
| Prednisone | 13 | $88 | $7 |
2016: 9 drugs
| Spiriva | 50 | $17,395 | $348 |
| Advair Diskus | 30 | $12,202 | $407 |
| Symbicort | 33 | $9,446 | $286 |
| Anoro Ellipta | 17 | $5,444 | $320 |
| Proair Hfa | 18 | $1,148 | $64 |
| Ventolin Hfa | 15 | $828 | $55 |
| Mycophenolate Mofetil | 13 | $695 | $53 |
| Azithromycin | 17 | $592 | $35 |
| Pantoprazole | 19 | $141 | $7 |
2015: 10 drugs
| Spiriva | 51 | $18,781 | $368 |
| Symbicort | 28 | $8,497 | $303 |
| Advair Diskus | 18 | $6,925 | $385 |
| Proair Hfa | 32 | $1,860 | $58 |
| Ethambutol | 22 | $1,015 | $46 |
| Azithromycin | 22 | $927 | $42 |
| Rifampin | 22 | $629 | $29 |
| Prednisone | 13 | $145 | $11 |
| Omeprazole | 11 | $75 | $7 |
| Pantoprazole | 11 | $61 | $6 |
2014: 7 drugs
| Spiriva | 30 | $11,092 | $370 |
| Advair Diskus | 22 | $7,329 | $333 |
| Symbicort | 17 | $4,992 | $294 |
| Ethambutol | 25 | $1,151 | $46 |
| Proair Hfa | 14 | $1,028 | $73 |
| Azithromycin | 33 | $971 | $29 |
| Rifampin | 29 | $742 | $26 |
2013: 3 drugs
| Spiriva | 13 | $4,601 | $354 |
| Proair Hfa | 20 | $1,318 | $66 |
| Prednisone | 12 | $46 | $4 |
Money from drug and device companies
$152 in 2023
| 2023 | 3 | 7 | None | $152 |
| 2022 | 2 | 2 | None | $37 |
| 2021 | 3 | 5 | None | $100 |
| 2020 | 4 | 7 | None | $139 |
| 2019 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Trelegy Ellipta | $79 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $39 | 2 payments
|
| Novo Nordisk | Ozempic | $34 | 2 payments
|
See all 7 published payments
| GlaxoSmithKline | Meals · 2023-05-09 | Trelegy Ellipta | $30 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2023-03-28 | Ofev | $22 |
| GlaxoSmithKline | Meals · 2023-03-14 | Trelegy Ellipta | $28 |
| Novo Nordisk | Meals · 2023-03-02 | Ozempic | $21 |
| GlaxoSmithKline | Meals · 2023-01-24 | Trelegy Ellipta | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2023-01-10 | Stiolto Respimat | $17 |
| Novo Nordisk | Meals · 2023-01-05 | Ozempic | $14 |
See earlier years (2022, 2021, 2020, 2019)
2022: $37
| Butterfly Network | None | $21 | 1 payment
|
| Novo Nordisk | Ozempic | $17 | 1 payment
|
2021: $100
| GlaxoSmithKline | Trelegy Ellipta | $38 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $33 | 1 payment
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $29 | 2 payments
|
2020: $139
| Advanced Respiratory | Life 2000 Ventilation System | $37 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $33 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $33 | 2 payments
|
2019: $15
| GlaxoSmithKline | Trelegy Ellipta | $15 | 1 payment
|
Professional record
- NPI
- 1174697783
- Licence
- CA G85799California G85799: Current · expires 2027-11-30
- Trained
- University of Texas Medical Branch at Galveston, 1993
- Group
- Sutter Bay Medical Foundation · Aretaeus Telemedicine Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G857990
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 1375 University Ave, Healdsburg, CA, 95448
- NPI first listed
- 2006-11-17
- NPI last updated
- 2025-10-15
- NPI record certified
- 2025-10-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.